NO20050398L - Nye adenosinanaloger og deres anvendelse som farmasoytiske midler - Google Patents
Nye adenosinanaloger og deres anvendelse som farmasoytiske midlerInfo
- Publication number
- NO20050398L NO20050398L NO20050398A NO20050398A NO20050398L NO 20050398 L NO20050398 L NO 20050398L NO 20050398 A NO20050398 A NO 20050398A NO 20050398 A NO20050398 A NO 20050398A NO 20050398 L NO20050398 L NO 20050398L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical agents
- adenosine analogues
- new adenosine
- compounds
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02014324A EP1375508A1 (fr) | 2002-06-27 | 2002-06-27 | Dérivés de l'adénosine N6-substitués et leur utilisation comme médicament |
PCT/EP2003/006749 WO2004003002A1 (fr) | 2002-06-27 | 2003-06-26 | Nouveaux analogues de l'adenosine et leur utilisation comme agents pharmaceutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050398L true NO20050398L (no) | 2005-01-25 |
Family
ID=29716849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050398A NO20050398L (no) | 2002-06-27 | 2005-01-25 | Nye adenosinanaloger og deres anvendelse som farmasoytiske midler |
Country Status (19)
Country | Link |
---|---|
EP (2) | EP1375508A1 (fr) |
JP (1) | JP2006501178A (fr) |
KR (1) | KR20050014888A (fr) |
CN (1) | CN1671728A (fr) |
AR (1) | AR039697A1 (fr) |
AU (1) | AU2003280141A1 (fr) |
BR (1) | BR0312428A (fr) |
CA (1) | CA2490253A1 (fr) |
HR (1) | HRP20041209A2 (fr) |
IL (1) | IL165934A0 (fr) |
MA (1) | MA27465A1 (fr) |
MX (1) | MXPA04012815A (fr) |
NO (1) | NO20050398L (fr) |
PE (1) | PE20040584A1 (fr) |
PL (1) | PL375197A1 (fr) |
RU (1) | RU2005101872A (fr) |
TW (1) | TW200500376A (fr) |
WO (1) | WO2004003002A1 (fr) |
ZA (1) | ZA200410062B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0616111B8 (pt) | 2005-09-21 | 2021-05-25 | Pfizer Ltd | derivados de carboxamida, composição farmacêutica, uso dos mesmos e combinação |
JP2007153789A (ja) * | 2005-12-05 | 2007-06-21 | Mitsui Chemicals Inc | 光学活性3−アミノピロリジン誘導体の製造方法 |
EP2025674A1 (fr) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament |
EP2582709B1 (fr) | 2010-06-18 | 2018-01-24 | Sanofi | Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases |
EP2567959B1 (fr) | 2011-09-12 | 2014-04-16 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1545645A1 (de) * | 1965-12-06 | 1969-08-21 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von disubstituierten Adenosin-Derivaten |
AU575438B2 (en) * | 1984-10-26 | 1988-07-28 | Warner-Lambert Company | N6 - substituted deoxyribose analogues of adenosines |
US4755594A (en) * | 1986-01-31 | 1988-07-05 | Warner-Lambert Company | N6 -substituted adenosines |
AU8276187A (en) * | 1986-10-31 | 1988-05-25 | Warner-Lambert Company | Selected n6-substituted adenosines having selective a2 binding activity |
WO1997033591A1 (fr) * | 1996-03-13 | 1997-09-18 | Novo Nordisk A/S | Procede de traitement d'affections associees aux cytokines chez les mammiferes |
UA51716C2 (uk) * | 1996-07-08 | 2002-12-16 | Авентіс Фармасьютікалз Продактс Інк. | Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування |
US6376472B1 (en) * | 1996-07-08 | 2002-04-23 | Aventis Pharmaceuticals, Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
AU7449598A (en) * | 1997-05-23 | 1998-12-11 | Nippon Shinyaku Co. Ltd. | Medicinal composition for prevention or treatment of hepatopathy |
GB9723589D0 (en) * | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
GB9723566D0 (en) * | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-06-27 EP EP02014324A patent/EP1375508A1/fr not_active Withdrawn
-
2003
- 2003-06-18 AR ARP030102151A patent/AR039697A1/es unknown
- 2003-06-25 PE PE2003000640A patent/PE20040584A1/es not_active Application Discontinuation
- 2003-06-26 JP JP2004516688A patent/JP2006501178A/ja active Pending
- 2003-06-26 CA CA002490253A patent/CA2490253A1/fr not_active Abandoned
- 2003-06-26 KR KR10-2004-7021262A patent/KR20050014888A/ko not_active Application Discontinuation
- 2003-06-26 RU RU2005101872/04A patent/RU2005101872A/ru not_active Application Discontinuation
- 2003-06-26 PL PL03375197A patent/PL375197A1/xx not_active Application Discontinuation
- 2003-06-26 WO PCT/EP2003/006749 patent/WO2004003002A1/fr active Application Filing
- 2003-06-26 IL IL16593403A patent/IL165934A0/xx unknown
- 2003-06-26 EP EP03740352A patent/EP1527083A1/fr not_active Withdrawn
- 2003-06-26 AU AU2003280141A patent/AU2003280141A1/en not_active Abandoned
- 2003-06-26 CN CNA038179660A patent/CN1671728A/zh active Pending
- 2003-06-26 TW TW092117351A patent/TW200500376A/zh unknown
- 2003-06-26 MX MXPA04012815A patent/MXPA04012815A/es not_active Application Discontinuation
- 2003-06-26 BR BR0312428-2A patent/BR0312428A/pt not_active IP Right Cessation
-
2004
- 2004-12-13 ZA ZA200410062A patent/ZA200410062B/xx unknown
- 2004-12-24 HR HR20041209A patent/HRP20041209A2/hr not_active Application Discontinuation
- 2004-12-24 MA MA28022A patent/MA27465A1/fr unknown
-
2005
- 2005-01-25 NO NO20050398A patent/NO20050398L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2490253A1 (fr) | 2004-01-08 |
JP2006501178A (ja) | 2006-01-12 |
BR0312428A (pt) | 2005-04-26 |
TW200500376A (en) | 2005-01-01 |
MA27465A1 (fr) | 2005-08-01 |
PE20040584A1 (es) | 2004-11-03 |
ZA200410062B (en) | 2008-08-27 |
EP1375508A1 (fr) | 2004-01-02 |
RU2005101872A (ru) | 2005-08-10 |
MXPA04012815A (es) | 2005-02-24 |
WO2004003002A1 (fr) | 2004-01-08 |
IL165934A0 (en) | 2006-01-15 |
EP1527083A1 (fr) | 2005-05-04 |
PL375197A1 (en) | 2005-11-28 |
AR039697A1 (es) | 2005-03-09 |
CN1671728A (zh) | 2005-09-21 |
KR20050014888A (ko) | 2005-02-07 |
AU2003280141A1 (en) | 2004-01-19 |
HRP20041209A2 (en) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074872L (no) | Pyrazoler | |
ATE442349T1 (de) | Diacylglycerol-acyltransferase-hemmer | |
NO20081482L (no) | Delta- og epsilon-krystallformer for imatinibmesylat | |
NO20054876L (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
NO20060908L (no) | Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse | |
NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
WO2007082808A3 (fr) | Thiazoles en tant qu'inhibiteurs de 11 beta-hsd1 | |
NO20055680L (no) | Heksahydropyridoisokinoliner som DPP-IV-inhibitorer | |
MX2008002062A (es) | Uso de derivados de tienopiridona como activadores de ampk y composiciones farmaceuticas que los contienen. | |
NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
NO20091229L (no) | Kombinasjonsterapi med SGLT-2 inhibitorer og deres farmasoytiske sammensetninger | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
WO2007060140A3 (fr) | Inhibiteurs de diacylglycérol acyltransférase (dgat) | |
NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
EA200800056A1 (ru) | Каннабиноидный активный фармацевтический ингредиент для лекарственных форм | |
MX2008012017A (es) | Pirazoles como inhibidores de 11-beta-hsd1. | |
CY1108900T1 (el) | Πολυθειωμενα γλυκοζιδια και αλατα αυτων | |
MX2007010532A (es) | Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii. | |
NO20054868L (no) | CaSr antagonist | |
NO20071617L (no) | Indozolonderivater som 11B-HSD1-inhibitorer | |
NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
SE0102300D0 (sv) | Compounds | |
WO2008042688A3 (fr) | Inhibiteurs de co-transporteur 2 de sodium glucose et procédés d'utilisation de ceux-ci | |
TW200736223A (en) | N-(pyridin-2-yl)-sulfonamide derivatives | |
NO20050828L (no) | lndol-3-svovelderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |